Ryan Schaffer - 14 Jun 2022 Form 4 Insider Report for Expensify, Inc. (EXFY)

Signature
/s/ Ryan Schaffer
Issuer symbol
EXFY
Transactions as of
14 Jun 2022
Net transactions value
+$6,043
Form type
4
Filing time
27 Jun 2022, 17:18:33 UTC
Previous filing
16 Nov 2021
Next filing
12 Jul 2022

Key filing fact

Ryan Schaffer filed Form 4 for Expensify, Inc. (EXFY) on 27 Jun 2022.

Key facts

  • This page summarizes Ryan Schaffer's Form 4 filing for Expensify, Inc. (EXFY).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 27 Jun 2022, 17:18.

Change

  • Previous filing in this sequence was filed on 16 Nov 2021.
  • Current net transaction value: +$6,043.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

EXFY transaction

Class A Common Stock

Award

Transaction value
$6,167
Shares
+354
Change %
+0.59%
Price
$17.42
Shares after
60,388
Date
14 Jun 2022
Ownership
Direct
Footnotes
F1
EXFY transaction

Class A Common Stock

Award

Transaction value
$0
Shares
+18
Change %
+0.03%
Price
$0.000000
Shares after
60,406
Date
14 Jun 2022
Ownership
Direct
Footnotes
F2
EXFY transaction

Class A Common Stock

Tax liability

Transaction value
$123
Shares
-7
Change %
-0.01%
Price
$17.60
Shares after
60,399
Date
14 Jun 2022
Ownership
Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased pursuant to the Expensify, Inc. 2021 Stock Purchase and Matching Plan ("SPMP").
F2 Shares granted as matched shares pursuant to the SPMP.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .